10-Q: GoHealth Reports Steep Losses, Impairment Charges Amid Medicare Advantage Pullback

GoHealth, Inc. reported a significant net loss and substantial impairment charges for Q3 2025, driven by a strategic pullback in Medicare Advantage activity and tightening health plan economics, raising substantial doubt about its ability to continue as a going concern.

Summary

• Net revenues for the three months ended September 30, 2025, decreased by 71.1% to $34.2 million from $118.3 million in the prior year period.
• The company recorded a net loss of $313.9 million for Q3 2025, a significant decline from a net income of $15.4 million in Q3 2024.
• Adjusted EBITDA for Q3 2025 was a loss of $47.1 million, worsening from a loss of $12.1 million in Q3 2024.
• Total operating expenses more than doubled to $322.1 million in Q3 2025, primarily due to $206.2 million in indefinite and long-lived asset impairment charges.
• Impairment charges included $159.0 million for definite-lived amortizable intangible assets (written down to zero), $20.0 million for indefinite-lived trade names, $22.7 million for capitalized software, property and equipment, and $4.5 million for operating lease assets.
• Submissions decreased by 56.6% to 72,183 in Q3 2025, and Sales per Submission fell by 34.3% to $461.
• Direct Operating Cost per Submission increased by 14.0% to $756 in Q3 2025.
• The company issued 4,766,219 shares of Class A common stock to lenders on August 6, 2025, as consideration for debt amendments, representing 16.66% of post-closing shares.
• A new Superpriority Senior Secured Credit Agreement was entered into on August 6, 2025, for $115.0 million, including $80.0 million in new-money term loans and $35.0 million in roll-up term loans.
• Management implemented a reduction in force in November 2025, impacting approximately 487 employees, as part of cost-saving initiatives.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to severe financial losses, substantial asset impairment charges, significant declines in key operating metrics, explicit 'going concern' doubt, and a large-scale reduction in force. While strategic actions are being pursued, the immediate financial performance and outlook are highly concerning.

Positives

• Management is actively pursuing various strategic alternatives, including refinancings, securitizations, mergers, acquisitions, or restructurings, to enhance financial flexibility and long-term positioning.
• The Board of Directors established a Transformation Committee with exclusive power to review, formulate, and negotiate strategic alternatives.
• The company was in compliance with all financial covenants as of September 30, 2025, following recent debt amendments.
• The launch of GoHealth Protect during Q2 2025 partially offset declines in Medicare Advantage activity, though at lower per-submission revenue.
• Direct Operating Cost per Submission for the nine months ended September 30, 2025, decreased by 10.5% due to improvements in agent productivity through enhanced training programs and technology investments.

Negatives

• Net revenues for the three months ended September 30, 2025, decreased by 71.1% year-over-year, primarily due to a scale back in Medicare Advantage activity.
• The company reported a net loss of $313.9 million for Q3 2025, compared to a net income of $15.4 million in Q3 2024.
• Adjusted EBITDA for Q3 2025 was a loss of $47.1 million, significantly worse than the $12.1 million loss in Q3 2024.
• Total operating expenses increased by 100.1% in Q3 2025, largely due to $206.2 million in indefinite and long-lived asset impairment charges.
• Submissions decreased by 56.6% in Q3 2025, reflecting a reduced agent headcount and intentional pullback on Medicare Advantage activity.
• Sales per Submission decreased by 34.3% in Q3 2025, attributed to the shift in focus to lower-revenue GoHealth Protect products and a change in carrier mix.
• Direct Operating Cost per Submission increased by 14.0% in Q3 2025, mainly due to a higher proportion of external agent-generated submissions.
• Management's current financial projections indicate a significant likelihood of being unable to maintain compliance with debt covenants within the next twelve months, raising substantial doubt about the company's ability to continue as a going concern.
• A reduction in force impacting approximately 487 employees was announced in November 2025, indicating severe cost-cutting measures.
• The company recognized a $1.7 million loss on extinguishment of debt in Q3 2025.

Risks

• The company's liquidity condition may deteriorate, and it may be unable to comply with financial covenants under its debt agreements, including the minimum liquidity covenant in the Superpriority Credit Agreement, which could lead to lenders accelerating repayment of borrowings.
• The business may be harmed if relationships with health plan partners change or are lost, particularly if the company or its partners temporarily or permanently lose the ability to market and sell Medicare plans.
• Health plan partners may reduce commissions paid to the company or change underwriting practices, impacting sales, renewal rates, and financial results.
• Acquisitions or other strategic alternatives could disrupt the business, divert resources, increase expenses, distract management, and may not realize anticipated benefits.
• The company may not realize the expected benefits from strategic cash flow optimization and other cash management initiatives, including the reduction in force, which could negatively impact employee morale, culture, and ability to attract and retain talent.
• Ongoing legal proceedings, including a DOJ qui tam proceeding alleging False Claims Act and Anti-Kickback Statute violations, could result in significant damages, fines, penalties, or changes to business practices.
• Sales of a substantial number of Class A common stock shares in the public market, including those recently issued to lenders, could cause the stock price to decline and dilute existing shareholders.

Future Outlook

Management expects the industry shift toward retention and stability over broad enrollment growth in the Medicare Advantage landscape to continue through the 2025 AEP season. The company's scale-back in Medicare Advantage activity is anticipated to result in reduced revenues compared to the prior year. GoHealth intends to continue focusing on cost reduction, increasing effectiveness, and optimizing cash flow, including further reductions in infrastructure costs. Despite being in compliance with covenants as of September 30, 2025, management projects a significant likelihood of non-compliance within the next twelve months without successful implementation of mitigating strategic and operational initiatives.

Management Comments

• "We continue to observe significant changes to the Medicare Advantage landscape. Specifically, health plans have tightened plan economics by reducing prefunded marketing spend, adjusting broker compensation structures, and eliminating or consolidating low-margin plans."
• "We believe that these actions reflect a clear industry shift toward retention and stability rather than broad enrollment growth and believe this trend will continue through the 2025 AEP season."
• "In light of these dynamics, in the third quarter of 2025 we scaled back our Medicare Advantage activity for the 2025 AEP season and continued our focus on GoHealth Protect."
• "To preserve strategic flexibility, we have adopted and will continue to pursue a disciplined focus on retention of current customers over volume of new sales and a focus on cash preservation."
• "We are pursuing initiatives aimed at reducing costs, increasing effectiveness and optimizing cash flow. As part of those initiatives, we intend to focus our efforts on a reduction in infrastructure costs, including with respect to our technology platform and underlying network infrastructures."
• "In November 2025, we issued Worker Adjustment and Retraining Notification (WARN) Act notices to approximately 487 employees in relation to a reduction in force (RIF) at the Company's Chicago headquarters and remote workforce around the country. This decision was made after a thorough review of market conditions, favoring conservation of capital in the near-term amidst widespread pullback in benefits and offerings across Medicare Advantage health plans."
• "On August 6, 2025, the Company entered into a number of strategic capital and governance actions intended to enhance the Company’s financial flexibility, long-term positioning, and value for stockholders, as well as allowing for the pursuit of strategic alternatives, such as consolidation in a fragmented broker landscape."
• "Based on its evaluation, and following the entry into the Superpriority Credit Agreement and Amendment No. 14, management believes the Company’s current sources of liquidity will be sufficient to meet its projected operating requirements and debt obligations for the twelve months from the date of this Quarterly Report on Form 10-Q. However, our liquidity condition may deteriorate and/or we may be unable to comply with the financial covenants under our debt agreements, including the minimum liquidity covenant in the Superpriority Credit Agreement."

Industry Context

The announcement highlights a significant shift in the Medicare Advantage industry, moving away from broad enrollment growth towards retention and stability. Health plans are tightening plan economics, reducing marketing spend, adjusting broker compensation, and consolidating low-margin plans. This trend is forcing brokers like GoHealth to scale back Medicare Advantage activities and focus on cost preservation and strategic alternatives. The fragmented broker landscape suggests potential for consolidation, which GoHealth's newly formed Transformation Committee is exploring.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for direct industry comparison. However, the general commentary on 'tightening health plan economics' and 'widespread pullback in benefits and offerings across Medicare Advantage health plans' suggests that the challenges GoHealth faces are reflective of broader industry pressures impacting other brokers and health plans in the Medicare Advantage sector.

Corporate Governance

Legal Proceedings

• A derivative action alleging breaches of fiduciary duty and other claims, based on the previously resolved Securities Class Action, has reached an agreement in principle for settlement, subject to court approval. The settlement includes certain corporate reforms to be implemented by the company.
• The Department of Justice (DOJ) filed a complaint in partial intervention on May 1, 2025, in a pending qui tam proceeding. The lawsuit alleges violations of the False Claims Act and the Anti-Kickback Statute, specifically that the company was compensated and discriminated against individuals in violation of federal law. The complaint seeks treble damages, civil penalties, and costs. The company intends to vigorously defend against these allegations, but the ultimate outcome is not probable nor estimable at this time.

Related Party Transactions

• The company is party to various lease agreements with 220 W Huron Street Holdings LLC, 215 W Superior LLC, and Wilson Tech 5, LLC, all controlled by significant stockholders. Lease payments for these agreements totaled $1.3 million for the three months ended September 30, 2025, and $3.5 million for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders: Experienced significant dilution from the issuance of 4,766,219 Class A common shares to lenders and face potential further dilution from future strategic alternatives. The substantial net losses and asset impairments have severely eroded shareholder equity, leading to a deficit position.
• Employees: Approximately 487 employees were impacted by a reduction in force in November 2025, indicating job insecurity and potential negative impact on morale for remaining staff.
• Lenders: Received Class A common stock as consideration for debt amendments and provided new senior secured financing, indicating a restructuring of debt obligations and potentially increased control or influence over the company's future.
• Customers (Consumers): The company's strategic pullback in Medicare Advantage activity and tightening health plan economics may affect the variety and availability of plans offered, potentially impacting consumer choice and access to critical providers and medicines.
• Health Plan Partners: The company's strategic shift and cost-cutting measures reflect broader industry trends of tightening plan economics, reduced marketing spend, and adjusted broker compensation, which could impact the company's ability to attract and retain health plan partners.

Next Steps

• File a Shelf Registration Statement by November 17, 2025, as per the amended Registration Rights Agreement.
• Continue to implement cash management initiatives and further cost savings to improve cash flows and maintain compliance with debt covenants.
• The Transformation Committee will continue to review, formulate, and negotiate strategic alternatives, including refinancings, securitizations, mergers, acquisitions, or restructurings.
• Vigorously defend against the Department of Justice's qui tam proceeding related to alleged False Claims Act and Anti-Kickback Statute violations.
• Address the significant likelihood of being unable to maintain compliance with debt covenants within the next twelve months.

Key Dates

Recommendation

The filing reveals a company in severe financial distress, marked by a dramatic decline in revenue, substantial net losses, and significant asset impairment charges that have wiped out shareholder equity. The explicit disclosure of "substantial doubt about our ability to continue as a going concern" is a critical red flag. While management is pursuing strategic alternatives and cost reductions, these are reactive measures to a deteriorating situation. The ongoing legal proceedings, coupled with the dilution from recent capital raises and the potential for further dilution, present significant downside risks. The operational metrics show a sharp decline in new business volume and profitability per submission. Given these compounding negative factors, a seasoned investor would likely recommend a strong sell to mitigate further losses.

Keywords

Medicare Advantage, Health Insurance Marketplace, SEC Filing, Financial Results, Net Loss, Impairment Charges, Debt Restructuring, Going Concern, Cost Reduction, Layoffs, Strategic Alternatives, Broker Compensation, Regulatory Risk, GOCO